Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:19 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | CITADEL ADVISORS LLC | 1,442,489 3.600% | -719,413 (-33.28%) | View |
| 2024-11-14 10:00 am Sale | 13G | Vigil Neuroscience Inc. VIGL | Deep Track Capital LP | 1,553,996 3.920% | -2,095,730 (-57.42%) | View |
| 2024-10-09 6:22 pm Purchase | 13D | Vigil Neuroscience Inc. VIGL | Vida Ventures GP III L.L.C. | 5,042,012 12.700% | 26,083 (+0.52%) | View |
| 2024-08-12 5:02 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | Invus Global Management LLC | 1,991,038 5.300% | 1,991,038 (New Position) | View |
| 2024-03-29 4:30 pm Unchanged | 13G | Vigil Neuroscience Inc. VIGL | Artal International S.C.A. | 1,811,191 4.900% | 0 (Unchanged) | View |
| 2024-02-14 4:57 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | CITADEL ADVISORS LLC | 2,161,902 6.000% | -2,014 (-0.09%) | View |
| 2024-02-14 11:33 am Sale | 13G | Vigil Neuroscience Inc. VIGL | Deep Track Capital LP | 3,649,726 9.620% | -34,893 (-0.95%) | View |
| 2024-02-12 5:31 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | Flynn James E | 1,173,523 3.270% | -878,487 (-42.81%) | View |
| 2024-02-09 5:13 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | Artal International S.C.A. | 1,811,191 5.000% | -432,161 (-19.26%) | View |
| 2023-02-14 4:10 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | Hatteras Venture Partners VI LP | 1,565,578 4.400% | 1,565,578 (New Position) | View |
| 2023-02-14 08:02 am Purchase | 13G | Vigil Neuroscience Inc. VIGL | CITADEL ADVISORS LLC | 2,163,916 6.100% | 55,196 (+2.62%) | View |
| 2023-02-10 7:36 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | Artal International S.C.A. | 2,243,352 6.300% | -42,222 (-1.85%) | View |
| 2023-02-10 4:31 pm Purchase | 13D | Vigil Neuroscience Inc. VIGL | Vida Ventures GP III L.L.C. | 5,015,929 14.100% | 5,015,929 (New Position) | View |
| 2023-02-10 09:37 am Sale | 13G | Vigil Neuroscience Inc. VIGL | Flynn James E | 2,052,010 5.770% | -2,784 (-0.14%) | View |
| 2022-12-16 5:22 pm Unchanged | 13D | Vigil Neuroscience Inc. VIGL | Northpond Ventures LP | 4,214,498 11.800% | 0 (Unchanged) | View |
| 2022-08-26 5:11 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.500% | 2,739,727 (New Position) | View |
| 2022-08-23 4:16 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | Artal International S.C.A. | 2,285,574 6.400% | 2,285,574 (New Position) | View |
| 2022-08-22 4:16 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | Deep Track Capital LP | 3,684,619 9.990% | 3,684,619 (New Position) | View |
| 2022-08-16 5:19 pm Purchase | 13G | Vigil Neuroscience Inc. VIGL | Flynn James E | 2,054,794 5.780% | 2,054,794 (New Position) | View |
| 2022-01-21 4:39 pm Purchase | 13D | Vigil Neuroscience Inc. VIGL | Atlas Venture Fund XII L.P. | 4,808,896 17.000% | 4,808,896 (New Position) | View |